Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARPC1B pseudogene 1 (ARPC1BP1) is a non-coding genomic DNA sequence classified as a pseudogene and related to the functional ARPC1B gene that encodes a subunit of the actin-related protein 2/3 complex. Pseudogenes generally arise from gene duplication or retrotransposition events; they do not produce functional protein products and are not considered molecular targets for therapeutic intervention, drug interaction, or clinical biomarker use. If the query intends to identify a pharmacologically or biologically relevant target, the ARPC1B gene and protein, not its pseudogene, should be investigated[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARPC1B pseudogene 1 (ARPC1BP1).